122 related articles for article (PubMed ID: 22709649)
1. Peptide-based delivery to bone.
Aoki K; Alles N; Soysa N; Ohya K
Adv Drug Deliv Rev; 2012 Sep; 64(12):1220-38. PubMed ID: 22709649
[TBL] [Abstract][Full Text] [Related]
2. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic peptides: technological advances driving peptides into development.
Sato AK; Viswanathan M; Kent RB; Wood CR
Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
[TBL] [Abstract][Full Text] [Related]
4. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
5. Bone-targeting macromolecular therapeutics.
Wang D; Miller SC; Kopecková P; Kopecek J
Adv Drug Deliv Rev; 2005 May; 57(7):1049-76. PubMed ID: 15876403
[TBL] [Abstract][Full Text] [Related]
6. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
Yadav SC; Kumari A; Yadav R
Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
[TBL] [Abstract][Full Text] [Related]
7. Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone.
Trajkovski B; Petersen A; Strube P; Mehta M; Duda GN
Adv Drug Deliv Rev; 2012 Sep; 64(12):1142-51. PubMed ID: 22664228
[TBL] [Abstract][Full Text] [Related]
8. Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone.
Delgado JJ; Evora C; Sánchez E; Baro M; Delgado A
J Control Release; 2006 Aug; 114(2):223-9. PubMed ID: 16859798
[TBL] [Abstract][Full Text] [Related]
9. Ceramic/polymer nanocomposites with tunable drug delivery capability at specific disease sites.
Liu H; Webster TJ
J Biomed Mater Res A; 2010 Jun; 93(3):1180-92. PubMed ID: 19777574
[TBL] [Abstract][Full Text] [Related]
10. Discovering and improving novel peptide therapeutics.
McGregor DP
Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
[TBL] [Abstract][Full Text] [Related]
11. Strategies for enhanced peptide and protein delivery.
McCrudden MT; Singh TR; Migalska K; Donnelly RF
Ther Deliv; 2013 May; 4(5):593-614. PubMed ID: 23647277
[TBL] [Abstract][Full Text] [Related]
12. Is the oral route possible for peptide and protein drug delivery?
Morishita M; Peppas NA
Drug Discov Today; 2006 Oct; 11(19-20):905-10. PubMed ID: 16997140
[TBL] [Abstract][Full Text] [Related]
13. Phage display-derived peptides as therapeutic alternatives to antibodies.
Ladner RC; Sato AK; Gorzelany J; de Souza M
Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
[TBL] [Abstract][Full Text] [Related]
14. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.
Hengst V; Oussoren C; Kissel T; Storm G
Int J Pharm; 2007 Mar; 331(2):224-7. PubMed ID: 17150316
[TBL] [Abstract][Full Text] [Related]
15. Skeletal function and structure: implications for tissue-targeted therapeutics.
Shea JE; Miller SC
Adv Drug Deliv Rev; 2005 May; 57(7):945-57. PubMed ID: 15876397
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of amelogenin peptides on osteogenic differentiation in vitro: identification of possible new drugs for bone repair and regeneration.
Amin HD; Olsen I; Knowles JC; Donos N
Tissue Eng Part A; 2012 Jun; 18(11-12):1193-202. PubMed ID: 22320389
[TBL] [Abstract][Full Text] [Related]
17. Computational design of peptide ligands.
Vanhee P; van der Sloot AM; Verschueren E; Serrano L; Rousseau F; Schymkowitz J
Trends Biotechnol; 2011 May; 29(5):231-9. PubMed ID: 21316780
[TBL] [Abstract][Full Text] [Related]
18. Antibody conjugates and therapeutic strategies.
McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
[TBL] [Abstract][Full Text] [Related]
19. Localized delivery of growth factors for bone repair.
Luginbuehl V; Meinel L; Merkle HP; Gander B
Eur J Pharm Biopharm; 2004 Sep; 58(2):197-208. PubMed ID: 15296949
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery for musculoskeletal diseases.
Wang D; Miller SC; Kopecek J
Adv Drug Deliv Rev; 2005 May; 57(7):935-7. PubMed ID: 15876395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
